These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36685861)

  • 1. Pharmacogenomic variabilities in geo-ancestral subpopulations and their clinical implications: Results of collaborations with Hmong in the United States.
    Sun B; Wen YF; Culhane-Pera KA; Lo M; Straka RJ
    Front Genet; 2022; 13():1070236. PubMed ID: 36685861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Clinical Relevance of Differences in Allele Frequencies Found within Very Important Pharmacogenes between Hmong and East Asian Populations.
    Wen YF; Culhane-Pera KA; Thyagarajan B; Bishop JR; Zierhut H; Lo M; Xiong T; Peng K; Holzer K; Lee K; Straka RJ
    Pharmacotherapy; 2020 Feb; 40(2):142-152. PubMed ID: 31884695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype-Based Dosing Algorithms.
    Sun B; Wen YF; Culhane-Pera KA; Lo M; Xiong T; Lee K; Peng K; Thyagarajan B; Bishop JR; Zierhut H; Straka RJ
    Pharmacotherapy; 2021 Mar; 41(3):265-276. PubMed ID: 33202062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engaging Hmong adults in genomic and pharmacogenomic research: Toward reducing health disparities in genomic knowledge using a community-based participatory research approach.
    Culhane-Pera KA; Straka RJ; Moua M; Roman Y; Vue P; Xiaaj K; Lo MX; Lor M
    J Community Genet; 2017 Apr; 8(2):117-125. PubMed ID: 28074382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gout prevalence in the Hmong: a prime example of health disparity and the role of community-based genetic research.
    Roman YM; Lor K; Xiong T; Culhane-Pera K; Straka RJ
    Per Med; 2021 May; 18(3):311-327. PubMed ID: 33787318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Warfarin Dosing and Outcomes in Hmong Versus East Asians Patients: Real-World Data From an Integrated Healthcare System.
    Sun B; Yew PY; Wen YF; Chi CL; Straka RJ
    Cureus; 2022 Sep; 14(9):e28905. PubMed ID: 36249660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Identification of Novel
    Wen YF; Gaedigk A; Boone EC; Wang WY; Straka RJ
    Front Pharmacol; 2022; 13():867331. PubMed ID: 35387332
    [No Abstract]   [Full Text] [Related]  

  • 8. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to Type 2 Diabetes Mellitus Management for Older Hmong Patients with Minimal English Language Skills: Accounts from Caregivers, Case Managers, and Clinicians.
    Park L; Vang A; Yang B; Quanbeck A
    J Racial Ethn Health Disparities; 2023 Dec; 10(6):3062-3069. PubMed ID: 36512312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South-East and East Asian populations: A systematic review.
    Dorji PW; Tshering G; Na-Bangchang K
    J Clin Pharm Ther; 2019 Aug; 44(4):508-524. PubMed ID: 30980418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social-cultural, traditional beliefs, and health system barriers of hepatitis B screening among Hmong Americans: A case study.
    Fang DM; Stewart SL
    Cancer; 2018 Apr; 124 Suppl 7(Suppl 7):1576-1582. PubMed ID: 29578596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
    Mizzi C; Dalabira E; Kumuthini J; Dzimiri N; Balogh I; Başak N; Böhm R; Borg J; Borgiani P; Bozina N; Bruckmueller H; Burzynska B; Carracedo A; Cascorbi I; Deltas C; Dolzan V; Fenech A; Grech G; Kasiulevicius V; Kádaši Ľ; Kučinskas V; Khusnutdinova E; Loukas YL; Macek M; Makukh H; Mathijssen R; Mitropoulos K; Mitropoulou C; Novelli G; Papantoni I; Pavlovic S; Saglio G; Setric J; Stojiljkovic M; Stubbs AP; Squassina A; Torres M; Turnovec M; van Schaik RH; Voskarides K; Wakil SM; Werk A; Del Zompo M; Zukic B; Katsila T; Lee MT; Motsinger-Rief A; Mc Leod HL; van der Spek PJ; Patrinos GP
    PLoS One; 2016; 11(9):e0162866. PubMed ID: 27636550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genomic history of southwestern Chinese populations demonstrated massive population migration and admixture among proto-Hmong-Mien speakers and incoming migrants.
    Wang Y; Zou X; Wang M; Yuan D; Yang L; Zeng Y; Cheng F; Tang R; He G
    Mol Genet Genomics; 2022 Jan; 297(1):241-262. PubMed ID: 35031862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV Literacy and Associated Factors Among Hmong American Immigrants: Implications for Reducing Cervical Cancer Disparity.
    Beltran R; Simms T; Lee HY; Kwon M
    J Community Health; 2016 Jun; 41(3):603-11. PubMed ID: 26696118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population.
    Samarasinghe SR; Lee SB; Corpas M; Fatumo S; Guchelaar HJ; Nagaraj SH
    Clin Pharmacol Ther; 2024 Jun; ():. PubMed ID: 38837390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing Knowledge on Very Important Pharmacogenes CYP2C9 and CYP2C19 Variation for Precision Medicine in Resource-Limited Global Conflict Zones.
    Barlas İÖ; Sezgin O; Dandara C; Türköz G; Yengel E; Cindi Z; Ankaralı H; Şardaş S
    OMICS; 2016 Oct; 20(10):604-609. PubMed ID: 27726640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.
    Giri AK; Khan NM; Grover S; Kaur I; Basu A; Tandon N; Scaria V; ; ; Kukreti R; Brahmachari SK; Bharadwaj D
    Pharmacogenomics; 2014 Jul; 15(10):1337-54. PubMed ID: 25155935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Hmong-Related Health Problems: A Quick Guide for Healthcare Providers.
    Ali AH; Kang MS; Kaur K; Al Adhami S; Yuvienco CR
    Cureus; 2020 Aug; 12(8):e9808. PubMed ID: 32953320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leaves imitate trees: Minnesota Hmong concepts of heredity and applications to genomics research.
    Culhane-Pera KA; Moua M; Vue P; Xiaaj K; Lo MX; Straka RJ
    J Community Genet; 2017 Jan; 8(1):23-34. PubMed ID: 27822876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
    Dorji PW; Wangchuk S; Boonprasert K; Tarasuk M; Na-Bangchang K
    Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 32004143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.